Inventor
THOTA SAMBAIAH
US45 patents
⚠️ This page may combine multiple inventors who share the name “THOTA SAMBAIAH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
24 patentsUS7858633B2Dec 28, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC66 citations98
US7947698B2May 24, 2011
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC55 citations97
US7834024B2Nov 16, 2010
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC59 citations97
US7754714B2Jul 13, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC39 citations95
US7915273B2Mar 29, 2011
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC33 citations93
US7868013B2Jan 11, 2011
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC25 citations91
US10421752B2Sep 24, 2019
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC3 citations84
US9732073B2Aug 15, 2017
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9725419B2Aug 8, 2017
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC7 citations84
US9248190B2Feb 2, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US8815848B2Aug 26, 2014
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC8 citations84
US8012955B2Sep 6, 2011
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
RIGEL PHARMACEUTICALS INC7 citations84
US11198689B2Dec 14, 2021
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC2 citations73
US9481654B2Nov 1, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC5 citations73
US11827628B2Nov 28, 2023
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations63
US11667611B2Jun 6, 2023
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations63
US7569580B2Aug 4, 2009
Heterotricyclic compounds for use as HCV inhibitors
RIGEL PHARMACEUTICALS INC6 citations62
US9624229B2Apr 18, 2017
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
RIGEL PHARMACEUTICALS INC0 citations52
US9181220B2Nov 10, 2015
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
RIGEL PHARMACEUTICALS INC0 citations52
US9174964B2Nov 3, 2015
AMPK-activating piperidinyloxy-substituted 2,3-dihydro-1H-indene-1-amine compounds and pharmaceutical compositions including the same
RIGEL PHARMACEUTICALS INC1 citations52
US9040543B2May 26, 2015
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC0 citations52
US8895578B2Nov 25, 2014
Carboxamide, sulfonamide and amine compounds and methods for using the same
RIGEL PHARMACEUTICALS INC0 citations52
US9040527B2May 26, 2015
Pyrimidinediamine kinase inhibitors
RIGEL PHARMACEUTICALS INC0 citations51
US7358259B2Apr 15, 2008
HCV inhibitors and methods of using them
RIGEL PHARMACEUTICALS INC0 citations36
LI HUI
8 patentsUS8415365B2Apr 9, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI31 citations96
US8399472B2Mar 19, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI26 citations96
US8324200B2Dec 4, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI23 citations96
US8193197B2Jun 5, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI17 citations93
US8410093B2Apr 2, 2013
Cycloalkyl substituted pyrimidinediamine compounds and their uses
LI HUI9 citations84
US8299087B2Oct 30, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI11 citations84
US8962643B2Feb 24, 2015
Compositions and methods for inhibition of the JAK pathway
LI HUI3 citations63
US8729087B2May 20, 2014
Compositions and methods for inhibition of the JAK pathway
LI HUI0 citations52
SINGH RAJINDER
3 patentsHONG HUI
2 patentsUS8119809B2Feb 21, 2012
AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same
HONG HUI17 citations92
US8569340B2Oct 29, 2013
AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same
HONG HUI12 citations83